Tag Archives: BRIC

BRIC Nations' "Blossoming Healthcare Budgets" Revive Clinical Trials Opportunities

While some clinical trial sponsors have been driven out of the BRIC nations, a rise in rank for each country — Brazil, Russia, India, China — is expected over the next four years, indicating “blossoming healthcare budgets and markets that are ripe with opportunities for development”. According to a Thomson Reuters report, Overcoming Clinical Challenges in BRIC […]
Posted in Emerging Markets, Europe, Global, R&D | Also tagged , , | Leave a comment

BRIC Opportunities 2014

While the tide has been turning for pharma in the BRIC markets, they will continue to be important but only if the industry has learnt the hard lessons of the last few years. Speaking to Pharm Exec for the 2014 Industry Outlook, Reenita Das, Partner at Frost & Sullivan, says its now more important than […]
Posted in Global, Strategy | Also tagged , , , , , , , | Leave a comment

Emerging Countries' R&D: A Contest, but No Wipe Out

Emerging country markets are widely viewed as Big Pharma’s ace in the hole to replace declining rates of innovation in the US and Europe, with numerous studies claiming the BRICK nations (the ‘K’ is from South Korea) are at the center of a revolutionary global shift in the source points for new ideas —  what […]
Posted in Emerging Markets, Global, IP, R&D | Also tagged , , | 2 Comments
  • Categories

  • Meta